Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled study of flurbiprofen axetil injection for postoperative analgesia after abdominal surgery
CTR20210443Phase 3Active
- Sponsor
- Nanjing Youke Pharmaceutical
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flurbiprofen axetil, sponsored by Nanjing Youke Pharmaceutical. Started Apr 2021; status: active.
02
Drugs
flurbiprofen axetil
Beyond the preview
Go deeper on CTR20210443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210443.